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Anabolic Steroid and Human Growth
Hormone Abuse: Creating an Effective and
Equitable Ergogenic Drug Policy
George Fant
Many recent news stories have focused public attention on
ergogenic, or performance enhancing, drug abuse. Some of the
most memorable of these stories, such as the Olympic
Committee's revocation of Canadian sprinter Ben Johnson's
Olympic gold medal,1 or the death of former Oakland Raiders
football player Lyle Alzado,2 exemplify the tragedy and misfor-
tune that may accompany the abuse of these drugs. However, an
even more tragic side of ergogenic drug abuse exists that does not
make major headlines-adolescent abuse of these substances.
Adolescent abuse of anabolic steroids ("steroids"), one of the
more popular ergogenic drugs, is a widespread and growing prob-
lem. One study recently reported in U.S. News and World Report
found that one-half of the estimated one million American steroid
abusers are adolescents.' Furthermore, a 1988 study shockingly
found that children under the age of fifteen are more likely than
other groups to abuse steroids.4
Concerns about adolescent abuse of these drugs, as well as
concerns for public safety as a whole, led Congress to enact the
Anabolic Steroids Control Act of 1990 (the "Act").5 The Act
placed steroids on Schedule III of the Controlled Substances Act
(the "CSA"),6 thereby increasing the penalties for distributing
t A.B. 1992, Harvard University; J.D. Candidate 1995, University of Chicago.
Betsy Carpenter and Mike Tharp, A Game of Cat and Mouse, 105 US News and
World Rep 38 (Oct 10, 1988).
2 Robert Huizenga and Shelly Smith, A Doctor's Warning Ignored, Sports Illustrated
(July 8, 1991).
' See Joannie M. Schrof, Pumped Up, 112 US News and World Rep 54 (June 1,
1992).
' William E. Buckley, et al, Estimated Prevalence of Anabolic Steroid Use Among
Male High School Seniors, 260 J Am Medical Assn 3441 (1988).
Title XIX, Pub L No 101-647, 104 Stat 4851 (1990).
6 The CSA divides drugs and other controlled substances into five schedules depend-
ing on: (1) their potential for abuse; (2) their accepted medical uses within the United
States; and (3) their potential for psychological or physical addiction. See 21 USC § 812
(1993).
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steroids and for possessing steroids with the intent to distribute,
and criminalizing simple possession of the drug.7 The major
shortcoming of the Act, however, is the statutory scheme it creat-
ed to address another ergogenic drug, human growth hormone
("HGH"). Although the Act criminalized distribution and posses-
sion of HGH with the intent to distribute,' it did not place HGH
on any CSA schedule. Therefore, the penalties for distribution
and possession of HGH with the intent to distribute are less
severe than the analogous penalties associated with steroids
The Act's bifurcated approach to steroids and HGH under-
mines Congress's overall objective of eliminating ergogenic drug
abuse. The lower penalties associated with HGH use, combined
with the inability of any known drug test to detect HGH10 and
the common belief that HGH has fewer side effects than ste-
roids,11 present HGH as a clear alternative to steroids.
Furthermore, the disparity in criminal sanctions conflicts
with Congress's intent to protect the public. Although no quanti-
tative data exists addressing the long-term side effects of steroid
and HGH abuse,12 existing data concerning the short-term side
effects of steroid and HGH abuse suggest that HGH is as danger-
ous as steroids, if not more dangerous.13 Moreover, the data
suggest that HGH abuse is as widespread as steroid abuse. 4
The goal of this Comment is threefold. First, it shows that
HGH and steroids are so similar in terms of their limited clinical
' See 21 USC §§ 841, 844 (1994). Compare 21 USC § 333(e) (1988). 21 USC § 333(e)
was not repealed by the Act. Because the CSA provides for higher penalties for the same
offenses, however, most actions fall under the penalty provisions associated with the CSA
rather than this provision.
' Title XIX, Pub L No 101-647, 104 Stat 4851 (1990), codified at 21 USC § 333(f)
(1994).
' The Act placed steroids on Schedule III of the Act. Possession of Schedule III drugs
are punishable by up to one year imprisonment. Distribution and possession with the
intent to distribute steroids are punishable by up to five years imprisonment.
The Act also amended the FDA Act, making the distribution and possession with the
intent to distribute HGH punishable by up to five years imprisonment unless the recipi-
ent was under eighteen years old, in which case the maximum punishment is ten years
imprisonment. No penalty exists for possession of HGH under the FDA Act. See 21 USC §
844(a) (West 1988 & Supp 1993); 21 USC § 841 (b)(1)(D) (1988).
" See Vaughn I. Rickert, et al, Human Growth Hormone: A New Substance of Abuse
Among Adolescents?, 31 Clinical Pediatrics 723, 724 (1992).
" See Brian Hainline and Gary I. Wadler, Drugs and the Athlete, Contemporary
Exercise and Sports Medicine Series 55, 72 (F.A. Davis Company, 1989).
2 Id at 73.
13 See notes 61-101 and accompanying text. Compare notes 132-150 and accompany-
ing text.
"4 See notes 55-60 and accompanying text. Compare notes 119-130 and accompanying
text.
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uses, the number and demographics of abusers, and the side
effects associated with abuse that any difference in penalties is
unjustified. Second, the Comment compares the side effects and
medical uses of HGH with other drugs in Schedule III of the CSA
and concludes that HGH should be classified as a Schedule III
drug. Finally, this Comment explores alternative avenues of
deterrence, including education and social sanctions.
I. BACKGROUND
A meaningful comparison of HGH and steroids, as well as
any attempt to determine the similarities between HGH and
other Schedule III drugs, requires an in-depth understanding of
the drugs and their side effects. Therefore, this Comment first
addresses several issues, including:
(1) The clinical uses of steroids and HGH;
(2) The history of steroids and HGH abuse;
(3) The mechanisms by which steroids and HGH work;
(4) The estimated number and demographics of steroid
and HGH abusers; and
(5) The possible side effects associated with steroid and
HGH abuse.
A. Steroids
Steroids are patterned after testosterone, a male sex hor-
mone.15 Testosterone affects the human body in two ways. First,
it promotes constructive metabolism and tissue repair, an "ana-
bolic effect."16 Second, it induces secondary male sex characteris-
tics, an "androgenic effect."" Because athletes desire only the
anabolic effects of testosterone, steroids were constructed by
tinkering with the testosterone molecule in an attempt to isolate
its anabolic from its androgenic effects.18 However, because sci-
entists have been unable to isolate its anabolic effects complete-
ly,'9 steroids have certain undesired effects ("side effects").
Jon C. Wagner, Abuse of Drugs Used to Enhance Athletic Performance, 46 Am J of
Hospital Pharmacy 2059, 2062 (1989).
" Herbert A. Haupt, Anabolic Steroids and Growth Hormone, 21 Am J of Sports
Medicine 468 (1993).
17 Id.
18 Id.
19 Id.
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Steroids may be taken in two forms. They can be injected
into the body using hypodermic needles"° or administered oral-
ly.21 In oral form, steroids are "washed out" of the body more
quickly and are therefore detectable for a shorter period of
time.22 Orally administered steroids, however, may cause more
side effects than injected steroids." Steroid abusers often follow
a regime that meshes oral and injectable forms, a combination
known as "stacking."
4
1. Clinical use.
Although public discourse about steroids focuses on abuse by
athletes, steroids also have medical uses. These uses, however,
are very limited. The Food and Drug Administration ("FDA")
recommends steroids as a treatment only for some forms of ane-
mia, breast cancer, hereditary angioedema, allergic reactions to
insect bites, and certain viruses.25 Non-FDA recommended uses
include treatment for cachexia (wasting of the body associated
with chronic illnesses),26 osteoporosis,27 hypogonadism," and
athletic injuries."
20 Wagner, 46 Am J of Hospital Pharmacy at 2063 (cited in note 15).
21 Id.
22 Haupt, 21 Am J of Sports Medicine at 469 (cited in note 16).
2 Id.
24 Id.
21 Mitzi LaBree, A Review of Anabolic Steroids: Uses and Effects, 31 J of Sports Medi-
cine and Physical Fitness 618 (1991).
26 Id at 619.
27 Id.
Id. Symptoms of hypogonadism include the underdevelopment of the gonads, defi-
cient sperm production, deficient secretion of gonadal hormones, atrophy of the gonadal
region, deficient development of the secondary sexual characteristics, and, in prepubertal
males, an altered body shape characterized by a short trunk and long limbs. See
Stedman's Medical Dictionary 750 (Williams & Wilkins, 25th ed 1990).
One study found that, although steroid treatment did not contribute to an earlier
return to competition, it improved symptoms of athletes recovering from tendon ailments.
See M. T. F. Read, S. G. Motto, Tendo Achilles Pain: Steroids and Outcome, 26 British J
of Sports Medicine 15 (1992). Other studies have found stronger results, concluding that
steroid treatment following knee surgery decreases the length of hospital stays by 59
percent, reduces the number of painkillers used while hospitalized by 50 percent, and
enables ambulatory movement 38 percent faster. Joseph H. Vargas III and Dennis G.
Ross, Corticosteroids and Anterior Cruciate Ligament Repair, 17 Am J of Sports Medicine
532 (1989). Steroids have also been recommended as an anesthetic for musculoskeletal
overuse injuries and for treating swimmer's shoulder. Allen B. Richardson, Frank W.
Jobe, and H. Royer Collins, The Shoulder in Competitive Swimming, 8 Am J of Sports
Medicine 159, 163 (1980). See generally P. Kannus, M. Jarvinen, and S. Niittymaki, Long
or Short-Acting Anesthetic with Corticosteroid in Local Injections of Overuse Injuries? A
Prospective, Randomized, Double-Blind Study, 11 Intl J of Sports Medicine 397, 399
(1990).
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2. History.
Athletes have long claimed that steroids can increase lean
body mass, strength, and aggressiveness, and that steroids re-
duce recovery time during training.3" The first scientific studies
on steroids, however, mistakenly concluded that they had no
effect on athletic performance.31
Recent studies have confirmed what athletes have always
believed-steroids improve athletic performance. For example, a
1984 article concluded that steroids increase an athlete's strength
if the athlete combines steroid use with: (1) an intense weight
training program before and during the steroid regimen; and (2)
a high-protein, high-calorie diet.32 Other studies show that ste-
roid use increases lean body mass.33 In 1987, the American Col-
lege of Sports Medicine finally acknowledged the anabolic poten-
tial of steroids.34
'o See Hainline and Wadler, Contemporary Exercise and Sports Medicine Series at 72
(cited in note 11); Jon C. Wagner, Enhancement of Athletic Performance with Drugs: An
Overview, 12 Sports Medicine 250, 257 (1991); Herbert A. Haupt and George D. Rovere,
Anabolic Steroids: A Review of the Literature, 12 Am J of Sports Medicine 469, 481 (1984).
See also Michael S. Bahrke, et al, Psychological Moods and Subjectively Perceived Behav-
ioral and Somatic Changes Accompanying Anabolic Androgenic Steroid Use, 20 Am J of
Sports Medicine 717, 720 (1992) (survey of steroid abusers reporting that steroid use
resulted in increased muscle size, strength, and density, and faster recovery from work-
outs and injuries).
" Haupt and Rovere, 12 Am J of Sports Medicine at 469 (cited in note 30). See also
Allan J. Ryan, Anabolic Steroids are Fool's Gold, 40 Federation Proceedings 2682 (1981);
L. C. Johnson, et al, Effect of Anabolic Steroid Treatment on Endurance, 7 Medical Science
in Sports 287, 288 (1975) (noting that steroid treatment does not appear to affect the
development of endurance or strength, or the percentage of body fat).
32 Haupt and Rovere, 12 Am J of Sports Medicine at 482 (cited in note 30).
See M. Alen and K. Hakkinen, Physical Health and Fitness of an Elite Bodybuilder
during 1 Year of Self-Administration of Testosterone and Anabolic Steroids: A Case Study,
6 Intl J of Sports Medicine 24, 26 (1985). But see D. Economos and D. A. Crabtree, Analy-
sis of Strength and Endurance in Fast Twitch Skeletal Muscle After an Acute In Vitro
Exposure to an Anabolic Steroid, 31 J of Sports Medicine and Physical Fitness 433, 437
(1991) (study on adult rats failing to support the notion that steroids enhanced muscle
strength or endurance; speculating that steroids can block certain mechanisms of muscle
contraction, thus resulting in a decrease in force production); Steven J. Tingus and Rich-
ard C. Carlsen, Effect of Continuous Infusion of an Anabolic Steroid on Murine Skeletal
Muscle, 25 Medicine and Science in Sports and Exercise 485 (1993) (study on sedentary
rats finding that steroid injections had no significant effect on the strength or mass of
either fast twitch or slow twitch muscles; also finding no effect on the endurance of skele-
tal muscle).
" Since 1987, the position of the American College of Sports Medicine has been the
following:
(1) Anabolic-androgenic steroids combined with an adequate diet can contribute
to increases in body weight, often in the lean mass compartment.
(2) The gains in muscular strength achieved through high-intensity exercise and
proper diet can be increased by the use of anabolic-androgenic steroids in some
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Despite the medical community's capitulation, its reputation
and credibility among steroid users may have suffered irrepara-
ble damage."5 The medical community's original conclusions of
inefficacy differed so much from athletes' experiences that steroid
abusers began to distrust all scientific studies on steroids."6
Many athletes today disbelieve the magnitude and severity of the
side effects associated with steroid abuse because they suspect
that medical reports documenting these effects are incorrect and
serve primarily as scare tactics.37
To fill the information gap, many steroid abusers turn to The
Underground Steroid Handbook (the "Handbook"). This book is
written, edited, and revised by weight lifters who themselves
abuse steroids." A survey of steroid abusers shows that most
abusers find the Handbook "instrumental in designing their ste-
roid regimens" and believe it is reliable." The Handbook has
widened the rift between steroid abusers and the medical profes-
sion. It has also undermined the medical profession's attempts to
educate the public by disparaging and minimizing all scientific
individuals.
(3) Anabolic-androgenic steroids do not increase aerobic power or capacity for
muscular exercise.
American College of Sports Medicine, Position Stand on the Use of Anabolic-Androgenic
Steroids in Sports, 19 Medicine and Science in Sports and Exercise 534 (1987).
Haupt and Rovere, 12 Am J of Sports Medicine at 481 (cited in note 30).
Hainline and Wadler, Contemporary Exercise and Sports Medicine Series at 66
(cited in note 11).
37 Id.
3' The Handbook gives sources, approximate costs, effects, possible side effects, and
dosages for forty-six different ergogenic drugs, including steroids and HGH. It even at-
tempts to summarize scientific experiments conducted with these drugs. Paul J. Perry,
Kathleen H. Andersen, and William R. Yates, Illicit Anabolic Steroid Use in Athletes: A
Case Series Analysis, 18 Am J of Sports Medicine 422, 426 (1990).
" Id at 427. Among the "facts" listed in the handbook are:
(1) The more that you take, the more you'll grow (if you eat enough and train
right).
(2) Some brands work better than others.
(3) Orals do more damage to your liver than [intramuscular injectables].
(4) The less toxic an oral is to your liver, the less effective it is for growth.
(5) There is no such thing as taking too much steroid, it varies from person to
person. 'Too much' for one may not be enough for another.
(6) 'Too much' is only related to your health. No doctor, no researcher, no one
has determined the optimum dosage for athletic performance.
(7) Most of the people who have taken massive amounts of steroids and shot
their blood test results past the normal ranges didn't get ill, didn't die, and had
the test results drop into the normal range after the cessation of the drugs.
(8) Never assume that you are like 'most people' until you prove it.
Id at 426, quoting The Underground Steroid Handbook.
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and medical claims that steroid abuse can cause serious side ef-
fects.40
Believing steroids give athletes an unfair competitive advan-
tage, several sports organizations have banned steroid use. For
example, the NCAA,4 the International Olympic Committee
("IOC"), 42  and the National Football League ("NFL")43  have
banned steroid use among competitors. These organizations en-
force their bans through urinalysis or blood tests that detect
steroid use." Nevertheless, steroid abuse continues. 5
3. Mechanism.
Researchers have suggested five mechanisms that may cause
the ergogenic effects of steroids:
(1) Steroids increase production of proteins by increas-
ing the production of RNA, the nucleic acid that carries
the instructions for creating proteins. 6
(2) Steroids increase the retention of nitrogen, one of
the building blocks of proteins.47
(3) Steroids stimulate the release of endogenous growth
hormone, which has significant anabolic effects.4"
(4) Steroids lead to gains through psychological ef-
fects.49
40 The Handbook's opinion of medical claims is that
most of the stories you've heard about steroid side effects are untrue. There are
side effects and they are mostly all temporary. The various drug manufacturers
will list every possible side effect that could happen to both men and women
while on anabolic steroids. In the real world of healthy athletes we have never
seen such drastic reactions as pattern baldness, liver cancer, extreme sex chang-
es, etc.
This excerpt suggests that the medical profession is far from regaining the trust of steroid
abusers. Perry, Anderson, and Yates, 18 Am J of Sports Medicine at 427, quoting The
Underground Steroid Handbook (cited in note 38).
4' Wagner, 12 Sports Medicine at 254 (cited in note 30).
42 Id at 253.
4' LaBree, 31 J of Sports Medicine and Physical Fitness 618 (cited in note 25).
Id at 618, 619.
45 Id.
41 V. Rogozkin, Metabolic Effects of Anabolic Steroid on Skeletal Muscle, 11 Medicine
and Science in Sports 160, 161 (1979).
41 Wagner, 46 Am J of Hospital Pharmacy at 2062 (cited in note 15).
4' Haupt, 21 Am J of Sports Medicine 468 (cited in note 16).
41 In other words, the athlete thinks he should be able to train harder; therefore, he
does train harder, and, as a result, he experiences significant gains. See Wagner, 46 Am J
of Hospital Pharmacy at 2062 (cited in note 15). See also Gideon Ariel and William
Saville, Anabolic Steroids: The Physiological Effects of Placebos, 4 Medicine and Science in
Sports 124, 125 (1972) (revealing that athletes who were given placebos and told they
were receiving steroid treatment demonstrated significant strength increases).
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(5) Steroids reduce symptoms of fatigue in athletes,
allowing the athlete to train at high levels for longer
periods of time.5"
An important aspect of the ergogenic potential of steriods is
that the gains in muscle mass and strength caused by steroid
abuse can only be sustained through continued steroid use. Ste-
roids are so similar to natural testosterone that increased levels
of steroid use lead to decreased levels of natural testosterone.5
Even after steroid use is discontinued, the concentration of natu-
rally produced testosterone does not immediately return to nor-
mal levels.52 This reduced natural testosterone level, without
the artificial boost of circulating steroids, cannot support the in-
creased muscularity achieved during steroid abuse. Therefore,
upon cessation of steroid abuse, the size and strength gains
achieved with the help of steroids quickly disappear.53 Athletes
who discontinue steroid use also lose any psychological boost that
the drug provided, further increasing the loss of mass and
strength.54 Faced with the prospect of losing "hard-earned"
gains, the athlete is caught in a "steroid trap" and may elect to
continue using steroids indefinitely.
4. Prevalence.
The exact incidence of steroid abuse among amateur and
professional athletes is unknown but is suspected to be wide-
spread.55 Researchers also suspect that steroid abusers in this
0 Haupt, 21 Am J of Sports Medicine at 468 (cited in note 16) (observing that most
gains associated with steroid use were attributable to the drug's ability to reduce fatigue).
"' Hainline and Wadler, Contemporary Exercise and Sports Medicine Series at 58-59
(cited in note 11).
52 Id at 65-66.
Haupt, 21 Am J of Sports Medicine at 468 (cited in note 16).
4 Id.
" Hainline and Wadler, Contemporary Exercise and Sports Medicine Series at 56
(cited in note 11). A fifteen-year study found that 20 percent of intercollegiate athletes
abused steroids. Another study reached similar results, finding that 17 percent of varsity
college athletes reported using steroids. Id at 61, citing T. L. Dezelsky, J. V. Toohey, and
R. S. Shaw, Non-Medical Drug Use Behavior at Five United States Universities: A 15 Year
Study, 37 Bull Narc 49 (1985); H. G. Pope, D. L. Katz, and R. Champoux, Anabolic-Andro-
genic Steroid Use Among 1,010 College Men, 16 Phys Sportsmed 75 (1988).
Estimating abuse levels in international competition is more difficult, but anecdotal
evidence suggests that this kind of abuse is equally widespread. For example, at the 1983
Pan American Games in Caracas, Venezuela, nineteen competitors were disqualified when
their steroid use was detected by unannounced tests. Other competitors withdrew from
the games, probably to avoid detection. Haupt and Rovere, 12 Am J of Sports Medicine
469 (cited in note 30).
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group often do not report their steroid abuse because they fear
the sanctions associated with admitting steroid use.5"
Most steroid abusers, however, are not athletes competing on
elite or intercollegiate levels but rather non-competitive athletes
who take steroids for cosmetic reasons." A 1988 study conduct-
ed by W. E. Buckley found that 6.6 percent of all high school
male seniors under the age of eighteen had used or were current-
ly using steroids." Another study of high school students found
that those who took steroids generally obtained them through the
black market."
Steroid abuse by non-competitive athletes is especially trou-
bling because, although competitive athletes usually terminate
their steroid abuse after a competition, cosmetic users take ste-
roids indefinitely to maintain their appearance and physique. 0
Therefore, the "steroid trap" may lead these users to take even
more steroids than competitive athletes.
5. Side effects.
Scientists have associated numerous side effects with steroid
use, but the data documenting these effects may severely under-
estimate steroids' true side effects, since the data derives from
studies involving clinical dosages of steroids equalling as little as
0.1 percent of the dosages steroid abusers actually take.6 ' Even
at these low levels, however, steroids can cause severe side ef-
fects. Aside from clearly visible side effects such as acne,62 ste-
roid abuse can cause liver damage, 3 kidney failure,64 immune
Hainline and Wadler, Contemporary Exercise and Sports Medicine Series at 61
(cited in note 11). See also Buckley, 260 J Am Medical Assn at 3444 (cited in note 4).
Haupt, 21 Am J of Sports Medicine at 469 (cited in note 16).
Buckley, 260 J Am Medical Assn at 3442 (cited in note 4).
5 Robert Windsor and Daniel Dumitru, Prevalence of Anabolic Steroid Use by Male
and Female Adolescents, 21 Medicine and Science in Sports and Exercise 494, 495 (1989)
(surveying 1,010 high school students and finding that 85.2 percent of those responding
that they used steroids indicated that they obtained these drugs from the black market).
See also Hainline and Wadler, Contemporary Exercise and Sports Medicine Series at 61
(cited in note 11) (stating that 80 percent of the estimated $100 million spent annually on
steroids is spent on black market drugs); Buckley, 260 J Am Medical Assn at 3443 (cited
in note 4) (noting that 60 percent of male high school seniors who used steroids obtained
them on the black market).
Haupt, 21 Am J of Sports Medicine at 469 (cited in note 16).
Hainline and Wadler, Contemporary Exercise and Sports Medicine Series at 67
(cited in note 11).
62 Haupt, 21 Am J of Sports Medicine at 469 (cited in note 16).
Steroid abuse can lead to changes in liver functions and liver disorders such as
peliosis hepatis and hepatic tumors. Peliosis hepatis is a condition where blood-filled sacs
form in the liver. Although this disease has not yet been documented in athletes, doctors
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system deficiencies,65 circulatory problems,66 and heightened
have detected the disease in patients who have been given therapeutic doses of steroids
for an extended period of time; therefore, this disease may also occur in steroid abusers.
See Wagner, 12 Sports Medicine at 258 (cited in note 30). See also Hainline and Wadler,
Contemporary Exercise and Sports Medicine Series at 65 (cited in note 11); Jean D. Wil-
son and James E. Griffin, The Use and Misuse of Androgens, 29 Metabolism 1278, 1287
(1980); Wagner, 46 Am J of Hospital Pharmacy at 2062 (cited in note 15). In addition,
"hepatic" or liver tumors have been discovered in athletes who abuse steroids as well as in
patients who have been treated with steroids. One study documented thirty-six separate
instances of benign and malignant tumors in patients who received steroids for more than
twenty-four months. See, for example, T. M. Creagh, A. Rubin, and D. J. Evans, Hepatic
Tumours Induced by Anabolic Steroids in an Athlete, 41 J of Clinical Pathology 441
(1988); Hainline and Wadler, Contemporary Exercise and Sports Medicine Series at 65
(cited in note 11). Finally, athletes taking steroids have experienced elevations in liver
function. Haupt and Rovere, 12 Am J of Sports Medicine 469 (cited in note 30). See also
R. J. Shephard, D. Killinger, and T. Fried, Responses to Sustained Use of Anabolic Ste-
roid, 11 British J of Sports Medicine 170 (1977). But see Markku Alen, Androgenic Steroid
Effects on Liver and Red Cells, 19 British J of Sports Medicine 15 (1985) (stating that
liver function is mildly impaired because of sustained high-dose testosterone administra-
tion).
" Hainline and Wadler, Contemporary Exercise and Sports Medicine Series at 65
(cited in note 11).
' Steroid abuse depresses the body's immune system. The effects of these changes,
which could include an increased risk of cancer and opportunistic infections, are not yet
known. In addition, due to the increased incidence of needle sharing, steroid use increases
the risk of contracting Acquired Immune Deficiency Syndrome (AIDS) and Hepatitis B.
See Haupt, 21 Am J of Sports Medicine at 469 (cited in note 16); Howard M. Sklarek, et
al, AIDS in a 22 year old Bodybuilder Using Anabolic Steroid, 311 New England J of
Medicine 1701 (1984).
' Studies have suggested a causal relationship between steroid use and: (1) acute
myocardial infarction, Robert A. McNutt, et al, Acute Myocardial Infarction in a 22 Year
Old World Class Weight Lifter Using Anabolic Steroids, 62 Am J of Cardiology 164 (1988);
Stedman's at 779 (cited in note 28) (explaining that a myocardial infarction, one type of
heart attack, is a sudden insufficiency of blood supply to an area of the heart muscle,
usually as a result of a blockage of a coronary vessel); (2) cardiac enlargement, Tingus and
Carlson, 25 Medicine and Science in Sports and Exercise 485 (cited in note 33); B. De
Piccoli, Anabolic Steroid Use in Body Builders: An Echocardiographic Study of Left Ven-
tricle Morphology and Function, 12 Intl J of Sports Medicine 408 (Aug 1991) (steroids can
enlarge and thicken the left ventricle of the heart, reducing its flexibility and decreasing
its blood output); T. T. Kurowski and S. M. Czerwinski, Glucocorticoid Modulation of Car-
diac Mass and Protein, 22 Medicine and Science in Sports and Exercise 312, 314 (1990)
(enlargement can occur within two days, but some evidence suggests that the increased
mass is lost with prolonged treatment); (3) strokes, M. A. Frankle, Rodolfo Eichberg, and
Sally B. Zachariah, Anabolic Androgenic Steroids and a Stroke in an Athlete: Case Report,
69 Archives of Physical Medicine 632, 633 (1988); (4) high blood pressure, Deborah Riebe,
Bo Fernhall, and Paul D. Thompson, The Blood Pressure Response to Exercise in Anabolic
Steroid Users, 24 Medicine and Science in Sports and Exercise 633 (1992) (systolic and
diastolic blood pressure were elevated both during rest and during exercise in subjects
that used steroids); J. W. Lenders, et al, Deleterious Effects of Anabolic Steroids on Serum
Lipoproteins, Blood Pressure and Liver Function in Amateur Body Builders, 9 Intl J of
Sports Medicine 19, 22 (1988); and (5) in some cases, heart degeneration, T. E. Takala, et
al, Effects of Physical Training, Methandione and Their Combination on the Lysosomal
Hydrolytic. Activities in Dog Heart, 13 Intl J of Sports Medicine 52, 54 (1992) (steroid
abuse, in conjunction with exercise, significantly increases the activity of the heart's lyso-
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cholesterol levels. 7
Additionally, steroids have specific physiological side effects
within different sex and age groups. In males, these side effects
occur because steroids closely resemble testosterone but do not
completely mimic its functions. 8 While circulating steroids are
sufficiently similar to testosterone to convince the body to shut
off its natural testosterone producing mechanism,69 steroids are
not exact copies of testosterone and cannot accomplish some body
functions that depend on testosterone. For instance, a decrease in
the level of natural testosterone71 may reduce sperm produc-
tion,71 cause the testes to shrink,72 and alter the sex drive.73
somal hydrolytic enzymes, resulting in degeneration of heart tissue).
67 Steroid use decreases the ratio of high density lipoprotein cholesterol ("HDL"), or
"good cholesterol," to low density lipoprotein cholesterol ("LDL"), or "bad cholesterol." See,
for example, M. Alen and P. Rahkila, Serum Lipids in Power Athletes Self-Administering
Testosterone and Anabolic Steroids, 6 Intl J of Sports Medicine, 139, 141 (1985). See also
U. Zuliani, et al, Effects of Anabolic Steroids, Testosterone, and HGH on Blood Lipids and
Echocardiographic Parameters in Body Builders, 10 Intl J of Sports Medicine 62, 65
(1989) (steroid abuse in conjunction with HGH abuse leads to significant decrease in HDL
cholesterol). Although the lipid levels return to normal when steroid use is discontinued,
this altered HDLJLDL ratio increases the risk of cardiovascular disease. Lipids Research
Clinics Program, The Lipid Research Clinics Coronary Primary Prevention Trial Results: I.
Reduction in Incidence of Coronary Heart Disease, 251 J Am Medical Assn 351 (1984). See
also Andrew S. Weyrich, et al, The Effects of Testosterone on Lipids and Eicosanoids in
Cynomolgus Monkeys, 24 Medicine and Science in Sports and Exercise 333, 337 (1992)
(testosterone injections adversely affect cardiovascular risk by changing concentrations of
HDL); M. Alen and P. Rahkila, Reduced High-Density Lipoprotein-Cholesterol in Power
Athletes: Use of Male Sex Hormone Derivates, an Atherogenic Factor, 5 Intl J of Sports
Medicine 341, 342 (1984).
Haupt, 21 Am J of Sports Medicine at 469 (cited in note 16).
69 Wagner, 12 Sports Medicine at 258 (cited in note 30). See also Markku Alen, et al,
Androgenic-Anabolic Steroid Effects on Serum Thyroid, Pituitary and Steroid Hormones in
Athletes, 15 Am J of Sports Medicine 357, 360 (1987) (cessation of drug use did not lead to
a return of serum testosterone to initial values after 16 weeks of drug withdrawal, thus
indicating prolonged impairment of testicular endocrine function).
7' Haupt, 21 Am J of Sports Medicine at 469 (cited in note 16).
"' This condition can lead to oligospermia (small number of sperm in the semen) and
azoospermia (lack of sperm in the semen). Jonathan P. Jarow and Larry I. Lipshultz,
Anabolic Steroid-Induced Hypogonadotrophic Hypogonadism, 18 Am J of Sports Medicine
429, 431 (1990). American College of Sports Medicine, Position Stand on the Use of Anabo-
lic-Androgenic Steroids in Sports, 19 Medicine and Science in Sports and Exercise 534,
536, 538 (Oct 1987). See also Stedman's at 162, 1083 (cited in note 28).
72 Wagner, 12 Sports Medicine at 258 (cited in note 30). See also Tingus and Carlson,
25 Medicine and Science in Sports and Exercise at 492-93 (cited in note 33) (testes weight
was significantly decreased in mice treated with steroids); Janet A. Yu-Yahiro, et al, Mor-
phologic and Histologic Abnormalities in Female and Male Rats Treated with Anabolic
Steroids, 17 Am J of Sports Medicine 686, 687 (1989) (testes weight was significantly
decreased in rats treated with steroids).
"' While the effect is variable, studies show that an individual taking steroids often
has an increased sex drive early in the course of steroid use, but with further steroid use
the sex drive either decreases to normal or dips below normal. See Wagner, 12 Sports
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Prolonged steroid abuse may lead to infertility,7 4 gynecomastia
(male breast development),7" and male pattern baldness.7"
As might be expected, the side effects of steroids, a derivative
of a male sex hormone, are more pronounced and generally more
serious in female users. In addition to disorders common to both
sexes, such as kidney damage,77 female steroid abusers face de-
creased breast size,7" uteral abnormalities, 9 menstrual irregu-
larity or cessation, ° increased libido,1 and increased facial
hair.82 While these side effects disappear with cessation of ste-
roid use, 3 other side effects, such as deepening of the voice,"
increased clitoris size,85 and male pattern baldness,88 are irre-
versible.87
Steroid side effects among adolescents are even more devas-
tating. Most notably, adolescents may experience premature
epiphyseal closure of the long bones of their body, a condition in
which the growth areas on bones irreversibly fuse into one anoth-
er, prematurely arresting growth.'
Medicine at 258 (cited in note 30). See also Bahrke, 20 Am J of Sports Medicine at 717
(cited in note 30).
"4 Testosterone has been used for the last twelve to fifteen years as a controlled
method of male birth control by injecting relatively low doses of steroids weekly. No seri-
ous side effects have been reported. See Jay S. Cox, Presidential Address of the American
Orthopaedic Society for Sports Medicine: Drug Abuse in Sports, 18 Am J of Sports Medi-
cine 568, 569 (1990).
" Gynecomastia, or male breast development, results from an excess of estrogen in
males. Estrogen, a female sex hormone, is produced through the transformation of andro-
gen, a byproduct of steroid use. A steroid user can combat this condition by taking anti-
estrogen; breast size usually returns to normal without treatment once steroid use is
stopped. See Wagner, 12 Sports Medicine at 258 (cited in note 30).
76 Haupt, 21 Am J of Sports Medicine at 469 (cited in note 16).
7 Hainline and Wadler, Contemporary Exercise and Sports Medicine Series at 61
(cited in note 11).
78 Richard H. Strauss, Marrah T. Liggett, and Richard R. Lanese, Anabolic Steroid
Use and Perceived Effects in Ten Weight Trained Women Athletes, 253 J Am Medical Assn
2871 (1985).
7 Yu-Yahiro, 17 Am J of Sports Medicine at 687 (cited in note 72).
Haupt, 21 Am J of Sports Medicine at 470 (cited in note 16).
81 Id.
12 Strauss, Liggett, and Lanese, 253 J Am Medical Assn at 2871 (cited in note 78).
Haupt, 21 Am J of Sports Medicine at 470 (cited in note 16).
Id.
Id. See also Strauss, Liggett, and Lanese, 253 J Am Medical Assn at 2871 (cited in
note 78).
Haupt, 21 Am J of Sports Medicine at 470 (cited in note 16).
87 Id at 467.
88 See Wagner, 12 Sports Medicine at 258-59 (cited in note 30); Haupt, 21 Am J of
Sports Medicine at 470 (cited in note 16). In fully grown adults, premature epiphyseal
closure is not possible, but steroid abuse may lead to tendon degeneration and resulting
tendon ruptures. For instance, many patients who are treated for ruptures of the triceps
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Aside from these physiological side effects, steroids may also
cause adverse psychological reactions. These side effects, com-
monly known as "roid rages," cause a "Jekyll-and-Hyde personali-
ty.... where even the slightest provocation can cause an exagger-
ated, violent and often uncontrolled response."89 As a result, ar-
rest records are common among steroid users.9"
An uncontrolled tendency toward violent behavior is not,
however, the only emotional change attributed to steroid abuse.
A 1988 study of forty-one known abusers of steroids found that
22 percent were manic or depressive during exposure to, or with-
drawal from, steroids.91 Steroid use may also cause feelings of
euphoria or enthusiasm,92 irritability,93 hyperactivity, 4 para-
noia," and insomnia.9" Moreover, one study found that while
taking steroids, 12 percent of the athletes examined had experi-
enced psychotic symptoms such as hallucinations or delusions.97
tendon are steroid abusers. While once rare, this injury now occurs frequently. James P.
Stannard and Allan L. Bucknell, Rupture of the Triceps Tendon Associated with Steroid
Injections, 21 Am J of Sports Medicine 482, 484-85 (1993). See also Jeffrey T. Laseter and
Jeffrey A. Russell, Anabolic Steroid-Induced Tendon Pathology: A Review of the Literature,
23 Medicine and Science in Sports and Exercise 1, 3 (1991) (steroid use can decrease the
tensile strength of tendon). But see J. Wesley McWhorter, R. S. Francis, and R. A.
Heckmann, Influence of Local Steroid Injections on Traumatized Tendon Properties: A
Biomechanical and Histological Study, 19 Am J of Sports Medicine 435, 437-38 (1991)
(steroid injections have no deleterious effect on the rat Achilles tendon as measured
biomechanically or histologically).
" Haupt, 21 Am J of Sports Medicine at 470 (cited in note 16).
'0 Id.
" Harrison G. Pope and David L. Katz, Affective and Psychotic Symptoms Associated
with Anabolic Steroid Use, 145 Am J of Psychiatry 487 (1988). Some researchers have
attributed post-use depression to insecurity "caused by the loss of size and strength, loss
of peer group attention .... loss of exercise interest and intensity, . . . and the loss of ste-
roid euphoria." See Wagner, 12 Sports Medicine at 259 (cited in note 30). The depression
can be so debilitating that it can lead to suicidal tendencies. Haupt, 21 Am J of Sports
Medicine at 470 (cited in note 16).
9 Bahrke, 20 Am J of Sports Medicine at 720 (cited in note 30).
93 Id.
' J. P. Freinhar and W. Alvarez, Androgen-Induced Hypomania, 46 J of Clinical
Psychiatry 354 (1985).
95 Ian C. Wilson, Arthur J. Prange, and Patricia P. Lara, Methyltestosterone and
Imipramine in Men: Conversion of Depression to Paranoid Reaction, 131 Am J of Psychia-
try 21, 22 (1974).
Bahrke, 20 Am J of Sports Medicine at 720 (cited in note 30).
Pope and Katz, 145 J Am Psychiatry at 487 (cited in note 91). Until recently, no
clinical study had overcome the methodological shortcomings of case studies. In 1993,
however, Su and Pagliaro performed a double-blind, placebo-controlled experiment on the
neuropsychiatric effects of steroids. They concluded that steroids have a significant impact
on mood and behavior in normal male volunteers even during short-term, relatively low-
dose administration of steroids. Subjects experienced subtle but significant increases in (1)
positive mood and sexual arousal, (2) negative moods such as irritability, anger, and hos-
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These feelings of euphoria, well-being, libido, energy, and
self-esteem resulting from steroid use also create a high potential
for addiction.9" In fact, one study found evidence of acute and
delayed withdrawal symptoms "similar to those seen in opioid,
alcohol, and cocaine withdrawal,"99 and it documented some cas-
es in which steroid users began to use other street drugs in an
attempt to reduce the side effects of steroid withdrawal.' Fi-
nally, social factors also motivate addiction; real or perceived
social acceptance and approval among the user's peers drive
individuals to continue to abuse steroids. 1'
B. Human Growth Hormone
HGH, a hormone naturally secreted by the body's anterior
pituitary gland," 2 is responsible for normal human growth and
affects almost every tissue and organ in the body. Athletes first
turned to HGH because they believed that it could provide many
of the benefits of steroid use without two of its major drawbacks.
First, athletes mistakenly believed that the side effects associat-
ed with HGH were less severe than those of steroids.0 3 Second,
and perhaps more importantly, there was, and continues to be,
no effective test to detect HGH use.0 4
1. Clinical use.
Currently, HGH's only clinical use is in the treatment of
growth hormone deficiency.' In the future, HGH may be used
to treat osteoporosis, obesity, and trauma.1 6
tility, and (3) cognitive symptoms such as distractibility, forgetfulness, and confusion.
Tung-Ping Su, et al, Neuropsychiatric Effects of Anabolic Steroids in Male Normal Volun-
teers, 269 J Am Medical Assn 2760-64 (1993).
" Kenneth B. Kashkin and Herbert D. Kleber, Hooked on Hormones? An Anabolic
Steroid Addiction Hypothesis, 262 J Am Medical Assn 3166, 3167-68 (1989). Kashkin
concluded that steroids may be so addictive that they can "dominate and destroy the
user's personal life." Id at 3167. These findings helped motivate Congress to increase the
penalties associated with steroid use.
" Id at 3166.
'0 Id at 3168.
... In at least one case, physical and emotional addiction led to continued use despite
"a severe deterioration in the user's personal life that included drug dealing to support
the [steroid] habit." Kashkin and Kleber, 262 J Am Medical Assn at 3167 (cited in note
98).
102 Hainline and Wadler, Contemporary Exercise and Sports Medicine Series at 70
(cited in note 11).
o Id at 72.
104 Id.
10 Haupt, 21 Am J of Sports Medicine at 472 (cited in note 16).
" Hainline and Wadler, Contemporary Exercise and Sports Medicine Series at 72
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2. History.
Paralleling early steroids studies, current HGH studies have
not proven that HGH produces any ergogenic effect. °7 Although
studies on animals have shown that HGH increases the size and
weight of atrophied muscles,"' its effects on contractile ele-
ments-the portion of the muscle that contracts to provide func-
tion-is unclear.0 9 Therefore, the enlarged muscle may be larg-
er, but it may not be proportionally as strong. Furthermore, it is
unclear whether HGH triggers similar effects in healthy muscle
tissue."0
3. Mechanism.
Like steroids' anabolic effect, HGH's anabolic effect stems
from several mechanisms. First, as with steroids, HGH may
increase nitrogen retention,"' and it may increase the rate at
which amino acids are transported and transformed into pro-
teins."' Because proteins are the building blocks of muscle tis-
sue,"' HGH users experience quick gains in muscle mass.""
Second, HGH stimulates the conversion of fat into ener-
gy," 5 allowing quicker muscle growth because resources that
would have been used for energy may now be converted to mus-
cle tissue."6 Finally, although not yet proven by scientific
study, some gains from HGH use, in a fashion similar to steroids,
may stem from psychological factors."7 In other words, the
HGH user believes the drug will make him stronger; therefore,
he trains harder and becomes stronger.'
(cited in note 11). See also Virginia S. Cowart, Human Growth Hormone: The Latest Ergo-
genic Aid?, 16 Am J of Sports Medicine 175 (1988).
107 Haupt, 21 Am J of Sports Medicine at 471 (cited in note 16). ("There are no studies
available that investigate the ergogenic effects of growth hormone in athletes, and anec-
dotal reports on the effects of growth hormone are inconsistent.").
1 J. G. Macintyre, Growth Hormone and Athletes, 4 Sports Medicine 129, 136 (1987).
tog Id.
l'o Id.
" Haupt, 21 Am J of Sports Medicine at 471 (cited in note 16).
112 Id.
"3 Stedman's at 56 (cited in note 28).
114 Haupt, 21 Am J of Sports Medicine at 471-2 (cited in note 16).
15 Id.
116 Id.
17 See note 49 and accompanying text.
Il Haupt, 21 Am J of Sports Medicine at 468 (cited in note 16).
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4. Prevalence.
The high cost of obtaining HGH,"9 combined with the
screening requirements, production limits, and post-marketing
surveillance imposed by the few manufacturers of HGH, restrict
HGH abuse.12 Studies, however, have found an alarming in-
crease in the number of athletes who inquire about HGH; some
studies have reported that HGH has replaced steroids as the
"ergogenic drug of choice."'21 Furthermore, the Handbook gives
HGH rave reviews, further fueling demand. 2 '
These qualitative statements about the prevalence of HGH
have been supported by quantitative data. One study surveyed
224 male and 208 female tenth-grade students and found that 5
percent of males participating in the survey had prior contact
with HGH.'23 By comparison, in the same survey, 5 to 11 per-
cent of males admitted some steroid use.'24 The survey also
found that HGH users take the drug regularly; 70 percent of
HGH users indicated that they used HGH more than one time
per month.'25 The demographics of tenth-grade HGH users is
even more frightening than the demographics of tenth-grade
steroid users: 78 percent of tenth-grade steroid users participated
"' Some estimates place the cost between $1,000 and $1,500 for an eight-week supply.
Id at 471-72.
" See Council Report, Drug Abuse in Athletes: Anabolic Steroids and Human Growth
Hormone, 259 J Am Medical Assn 1703, 1704 (1988).
,21 Macintyre, 4 Sports Medicine at 136 (cited in note 108).
Hainline and Wadler, Contemporary Exercise and Sports Medicine Series at 72
(cited in note 11). The Handbook lauds the beneficial nature of HGH:
Wow, is this great stuffi It is the best drug for permanent muscle
gains .... People who use it can expect to gain 30 to 40 pounds of muscle in ten
weeks if they can eat about 10,000 calories per day ... we think this to be an-
other best buy .... This is the only drug that can remedy bad genetics as it will
make anybody grow.
Perry, Anderson, and Yates, 18 Am J of Sports Medicine at 426 (cited in note 38).
The Handbook downplays the possible side effects of HGH:
A few side effects can occur, however. It may elongate your chin, feet and hands,
but this is arrested with cessation of the drug. Diabetes in teenagers is possible
with it. It can also thicken your ribcage and wrists. Massive increase in weight
over such a short time can, of course, give you heart problems.
Id.
The Handbook's final conclusion on HGH is that HGH "is the biggest gamble that an
athlete can take, as the side effects are irreversible. Even with all that, we LOVE the
stuff." Id.
"2 Rickert, 31 Clinical Pediatrics at 725 (cited in note 10).
1 4 Id at 723.
12 Id.
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in competitive sports, but only 50 percent of tenth-grade HGH
users were competitive athletes.126
This survey presents insights into the motivations underly-
ing HGH abuse. All users reported taking HGH as a means of
increasing body size and strength; many hoped to strengthen
tendons and ligaments as well.2 7 HGH abuse was also driven
by its undetectability and its ability to reduce the level of fat
stores within the body while building muscle.'28
Furthermore, half of all users in the survey could not identi-
fy a single common side effect.'29 Therefore, dissuaded from us-
ing steroids because of its widely known side effects, some ath-
letes have started using HGH, believing the drug has few or no
side effects. Perhaps the most troubling reported cause of HGH
abuse is parents who administer HGH to their child because they
feel that they should help their athletically gifted, but small,
child succeed.'30
5. Side effects.
Researchers know as little about the toxicity of HGH as they
know about its ergogenic potential.' Almost every organ in the
body, however, depends on growth hormone for proper growth
and development;'32 therefore, HGH abuse potentially could dis-
rupt normal function in most body systems.
The side effects most closely linked to HGH abuse are acro-
megaly and gigantism.'33 Gigantism, characterized by a general
overgrowth of the entire body or any of its parts,' results
when children or adolescents with normal growth hormone levels
take HGH.'35 Individuals with gigantism usually suffer from
osteoporosis and muscle weakness;'36 many die of cardiac fail-
ure.13
7
.26 Id at 725.
1" Rickert, 31 Clinical Pediatrics at 725 (cited in note 10).
128 Id.
129 Id.
130 Hainline and Wadler, Contemporary Exercise and Sports Medicine Series at 72
(cited in note 11).
13' Id at 73.
132 Haupt, 21 Am J of Sports Medicine at 471 (cited in note 16).
133 Id at 472.
1 Stedman's at 644 (cited in note 28).
1 Haupt, 21 Am J of Sports Medicine at 471 (cited in note 16).
3 Although the muscle is larger, it is not as strong as normal muscle. Id at 472.
137 Id.
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In adults, HGH cannot cause gigantism because growth
zones in bones have sealed. It can, however, cause a related dis-
ease called acromegaly, 35 a condition marked by the progres-
sive enlargement of peripheral parts of the body, especially the
head, hands, and feet. 39 Like those suffering from gigantism,
acromegalacs may appear muscular, but their muscles are quite
weak.4 4 They may also suffer from osteoporosis 4 ' and diabe-
tes,'4 ' and they may bear an increased risk of cardiac fail-
ure.43 Furthermore, about one third of all men with acromegaly
become impotent, and almost all women have menstrual irregu-
larities.
44
HGH abuse has also been linked to peripheral neuropa-
thy, 45  cardiomyopathy,146  hypothyroidism, 47  and arthri-
tis. 148 Like steroid abuse, HGH abuse may also increase the
risk of AIDS and Hepatitis B.14 Finally, some researchers con-
sider HGH to have a high "potential for addiction." 5
II. THE ANABOLIC STEROIDS CONTROL ACT OF 1990
The Anabolic Steroids Control Act of 1990 (the "Act")15' sig-
nificantly changed the regulatory framework for the possession
and distribution of steroids and HGH. Prior to the Act, the unau-
thorized distribution of steroids carried a punishment of not more
than three years imprisonment or, if the recipient was a minor
under eighteen years old, not more than six years imprison-
.. Id at 471.
"3 The hands become broad and spade-like with sausage-like fingers. Facial features
become coarse as a result of increased growth of subcutaneous tissue. Stedman's at 18
(cited in note 28).
'40 Haupt, 21 Am J of Sports Medicine at 472 (cited in note 16).
141 Id.
142 Id.
"' Id (50 percent die by the age of fifty and 89 percent die by the age of sixty).
114 Haupt, 21 Am J of Sports Medicine at 472 (cited in note 16).
" Hainline and Wadler, Contemporary Exercise and Sports Medicine Series at 73
(cited in note 11).
1' Id. See also Stedman's at 248 (cited in note 28) (defining cardiomyopathy as a
condition which affects the heart muscle only, leaving other cardiac structures intact).
147 Wagner, 12 Sports Medicine at 260 (cited in note 30); Stedman's at 746 (cited in
note 28) (defining hyperthyroidism as an abnormality of the thyroid gland in which secre-
tion of thyroid hormone is usually increased and is no longer under regulatory control of
the hypothalamic-pituitary centers; hyperthyroidism is characterized by a hypermetabolic
state, usually with weight loss, tremulousness, and elevated plasma levels of thyroxin).
141 Wagner, 12 Sports Medicine at 260 (cited in note 30).
149 Haupt, 21 Am J of Sports Medicine at 472 (cited in note 16).
Wagner, 46 Am J of Hospital Pharmacy at 2065 (cited in note 15).
151 Anabolic Steroids Control Act, 104 Stat 4851.
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ment.'52 The only sanctions against unauthorized distribution of
HGH prior to the Act were provided by Title 21, Section 331 of
the United States Code, which required no more than one year
imprisonment. 15 3 Simple possession of either substance was not
criminalized.
Sponsors of the Act hoped to protect society as a whole, and
adolescents in particular, from the dangers of steroids and HGH.
Senator Biden, a leading and early supporter of the Act, attempt-
ed to stir support for the bill by arguing that steroids were detri-
mental to the health and morals of America's youth. 5 4 Further-
more, in several hearings, the Senate Judiciary Committee and
House Criminal Justice Committee focused particularly on ado-
lescent steroid use. 55
In the end, however, the desire to protect America's youth
was balanced against fairness concerns. Therefore, the version of
the bill eventually signed into law was less stringent than the
version originally proposed in either the Senate or the House.'56
Most notably, the original Senate version of the Act placed ste-
roids on Schedule II of the CSA. Despite the harsh sentences
traffickers of Schedule II drugs face,'57 the Senate Judiciary
,6 See Title II, § 2401, Pub L No 100-690, 102 Stat 4230 (1988), codified at 21 USC §
333(e) (1988).
'53 21 USC §§ 331, 333(a) (1988).
" In remarks on the floor, Biden concentrated on the dangers of adolescent abuse:
"[flar too many young athletes regularly abuse these dangerous substances, and too often
this abuse leads to serious physical and psychological injury." S 17336, 100th Cong, 2d
Sess (Oct 18, 1988), in 134 Cong Rec 151 (Oct 21, 1988) (statement of Senator Biden).
During Senate debate, Biden stated that steroid abuse was disturbing, not only
because of the serious health consequences, but because steroid abuse "is cheat-
ing .... [Siports offers a chance to learn some of society's most basic values. Those values
includes [sic], among others, dedication, drive, and sportsmanship. But the use of steroids
threatens to undermine these values." S 16615, 101st Cong, 2d Sess (Oct 2, 1990), in 136
Cong Rec 147 (Oct 24, 1990) (statement of Senator Byrd).
"5 Crime Control Act of 1990, HR Rep 101-681, 101st Cong, 2d Sess 70, 71 (Sept 5,
1990), reprinted in 1990 USCCAN 6472, 6474-75; Steroids in Amateur and Professional
Sports-The Medical and Social Costs of Steroid Abuse: Hearings Before the Committee
on the Judiciary, United States Senate, 101st Cong, 1st Sess 3 (1989) (statement of Sena-
tor Biden).
" See Anabolic Steroids Control Act, 104 Stat 4851. Compare The Steroid Trafficking
Act of 1990, S 1829, S Rep 101-433, 101st Cong, 2d Sess 13 (1989); Crime Control Act of
1990, HR Rep 101-681 at 70 (cited in note 155).
For example, as originally proposed, the House version would have amended the
CSA to provide criminal penalties for coaches and other physical trainers and advisers
who persuade or induce any person to possess illegally or use steroids. This offense would
have been punishable by up to two years imprisonment, or up to five years if the person
was under eighteen years of age. Crime Control Act of 1990, HR Rep 101-681 at 70 (cited
in note 155).
,' Trafficking of a Schedule II drug carries a maximum sentence of fifteen years im-
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Committee felt that the dangers of steroids warranted these high
penalties.158
Two arguments against placing steroids on Schedule II, how-
ever, eventually prevailed. First, the House was uncomfortable
placing steroids in the same class as opium, heroin, and co-
caine.' 9 This "similar drugs" reasoning underscores the House
belief that when a drug is classified under the CSA, it should be
comparable to other drugs on the proposed Schedule. Second, the
House was reluctant to place steroids in Schedule II because it
did not believe that the maximum sentence for trafficking a
Schedule II drug, twenty years imprisonment, was appropriate
considering that the definition of "trafficker" under the CSA is
broad enough to include young people who share steroids with
others. 160
Therefore, in its final form, the Act classified steroids as a
Schedule III drug.'61 As a Schedule III drug, the first conviction
for distribution or possession with the intent to distribute ste-
roids carries a maximum sentence of five years imprisonment
and/or a fine of not more than $250,000.162 Subsequent convic-
prisonment for the first offense and thirty years imprisonment for subsequent offenses.
See 21 USC § 841 (1994).
" The Senate Report on the Steroid Trafficking Act of 1990 stated:
[Siteroids have a high potential for abuse. An estimated 1 million Americans use
anabolic steroids for nonmedical reasons; 500,000 of these users are high school
children. Second, steroids are indicated for the treatment of certain medical
conditions, including specific forms of anemia and reproductive disorders. The
committee notes, however, that with the development of new drugs and given
the harmful side effects associated with steroids therapy, steroids are the prima-
ry or favored pharmacological treatment for a decreasing number of medical
disorders. Finally, steroid abuse may lead to severe psychological and physical
dependence .... The committee concludes that the abuse potential of steroids is
similar to that of cocaine hydrochloride and other so-called hard drugs, and that
steroids should be regulated under the safeguards and controls of schedule II
substances.
The Steroid Trafficking Act of 1990, S 1829, S Rep No 101-433, 101st Cong, 2d Sess 13
(1989).
"' Anabolic Steroids Control Act of 1990: Hearings on HR 4658 Before the Subcom-
mittee on Crime of the Committee on the Judiciary, 101st Cong, 2d Sess 14 (1990).
160 Id.
" Schedule III includes all drugs that fit the following description:
(A) The drug or other substance has a potential for abuse less than the drugs or
other substances in Schedules I and II.
(B) The drug or other substance has a currently accepted medical use in treat-
ment in the United States.
(C) Abuse of the drug or other substance may lead to moderate or low physical
dependence or high psychological dependence.
21 USC § 812 (b)(1) (1994).
162 21 USC § 841(b)(1)(D) (1994).
439] ERGOGENIC DRUG POLICY
tions carry penalties of up to ten years imprisonment and/or a
fine of not more than $500,000.163 If the recipient of the drug is
under twenty-one years old, the CSA provides that the penalties
for the first offense are doubled, and those for subsequent penal-
ties are tripled.' Under the CSA, simple possession of steroids
carries a sentence of not more than one year imprisonment, a
fine of at least $1,000, or both.'
Congress, however, decided not to schedule HGH under the
CSA. Congress based this decision upon testimony that HGH was
not, at that time, as great a threat to adolescents as steroids."'
Congress did, however, amend the Food, Drug and Cosmetic Act
to criminalize HGH distribution or possession with the intent to
distribute. 7 Convictions for these offenses carry maximum
163 Id.
21 USC § 859 (1994).
16 21 USC § 844(a) (1994).
' Ronald G. Chesemore, Associate Commissioner for Regulatory Affairs of the FDA,
testified before the House that a consensus did not exist among the scientific community
regarding the abuse potential of HGH. He noted that HGH manufacturers had instituted
strict controls to prevent diversion of their product and that the FDA had found that the
illegal distribution of HGH was much less widespread than the illicit distribution of ste-
roids. See Hearing on HR 4658 at 47 (cited in note 159). The Senate also heard testimony
that although HGH had a "wide abuse potential," use would probably be limited by the
expense of the product. Abuse of Steroids in Amateur and Professional Sports: Hearings
Before the Subcommittee on Crime of the Committee on the Judiciary House of Represen-
tatives, 101st Cong, 2d Sess 85 (1990).
The most forceful testimony came from Dr. Louis Underwood, Professor of Pediatrics
at the University of North Carolina at Chapel Hill. Testifying before the House, he stated
that although steroids had a variety of different side effects, HGH had "very few unde-
sirable side effects and in the 25 years we have used it in the treatment of short children,
it has had amazingly few adverse effects." Id. Dr. Underwood proceeded to compare ste-
roids and HGH. He stated that HGH use would not cause aggressive behavior usually
found in steroid abusers. Id. Furthermore, he asserted that HGH did not cause psycholog-
ical dependency. Id. Finally, he concluded that unlike steroids, HGH had a rapid rate of
clearance from the body, "thereby not allowing it to build up in the body as in the case of
anabolic steroids." Id.
Dr. Underwood also testified that three adverse effects result from coupling HGH
with steroids. First, adverse psychological effects might result in the small children who
required HGH treatment for normal growth. Classifying HGH as a Schedule III drug
would instill a belief that these children were doing something wrong because they were
taking a highly regulated drug. Id. Second, scheduling HGH with steroids might create an
inconvenience for patients receiving HGH treatment. Tighter controls on HGH would
require children to return for treatment more often, necessitating more missed days of
school, thereby causing their parents to miss more days at work and increasing medical
and transportation costs. Id. Finally, scheduling HGH with steroids might cause a disrup-
tion in the supply for patients who currently received free growth hormone. Upon the
imposition of the stringent controls, both the manufacturer and the endocrinologist who
administered the drug would be less likely to offer free services due to additional registra-
tion costs. Id.
' 21 USC § 333(f)(1) (1994).
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terms of five years imprisonment. If, however, the recipient of
HGH is under eighteen years of age, the maximum term of im-
prisonment increases to ten years.16
Therefore, HGH and steroids are treated differently under
the Act in two significant ways. First, a subsequent conviction for
distribution or possession with the intent to distribute steroids
carries a much higher penalty than subsequent convictions for
HGH. Second, unlike simple possession of HGH, simple posses-
sion of steroids is criminalized.
These pivotal differences strongly affect the Act's ability to
deter trafficking and use of each substance. Criminalization of
simple possession places the threat of criminal sanctions upon
the trafficker's buyers. As a result, in order to avoid the social
stigma associated with a criminal charge, some users may refrain
from purchasing steroids, drying up the trafficker's demand.
Furthermore, criminalization of simple possession allows convic-
tion in cases where evidence does not support a trafficking con-
viction, thereby further undermining the steroid market.
Additionally, increased penalties for subsequent offenses
effectively combat trafficking. Because dealers are more likely to
face these increased penalties, it is likely that fewer people will
deal steroids. In addition, increased subsequent penalties more
effectively deter users who have been convicted of prior offenses.
Finally, the CSA's tripling of penalties associated with subse-
quent convictions for distribution and possession with the intent
to distribute steroids to persons under eighteen provides addi-
tional deterrence, at the margin, against drug sales to minors.
The statutory scheme created by the Act to cover HGH does
not criminalize simple possession, nor does it punish subsequent
offenses more severely. Therefore, it misses the opportunity to
control HGH abuse more effectively.
1 21 USC § 333(f)(2). The Act also authorized the Drug Enforcement Administration
(the "DEA") to investigate potential offenses involving the distribution of HGH, despite its
classification under the Food and Drug Act, 21 USC § 333(f)(5). This authorization result-
ed from a study by the Senate Judiciary Committee on FDA supervision of steroid traf-
ficking which found that the FDA was unequipped to handle the steroid problem. The
Report found that the FDA staff was inadequate, with only thirty-eight full-time person-
nel to control a $300 to $400 million illegal steroids trade. Furthermore, it found that
FDA investigators had neither the authority nor the expertise to attack the increasingly
sophisticated steroid trade, citing their inability to execute search warrants, conduct un-
dercover investigations, or carry guns. S Rep 101-433 at 9 (cited in note 158). Even so,
steroid investigations under the FDA resulted in the seizure of over $18 million worth of
illegal drugs, $500,000 in cash, numerous cars, guns, computers, and other equipment.
Hearings on HR 4658 at 42 (cited in note 159).
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III. DISCUSSION
An analysis of current medical and sociological knowledge
about HGH and steroids, in conjunction with an analysis of the
legislative history of the Act, yields three conclusions: (1) the
current distinction between the criminal sanctions for HGH and
steroid trafficking is artificial; (2) HGH should be reclassified as
a Schedule III drug; and (3) classification of HGH and steroids as
Schedule III drugs must be accompanied by educational pro-
grams to succeed in eradicating abuse.
A. The Act's Artificial Distinction Between HGH and Steroids is
Unjustified
HGH and steroids are similar in several ways. First, the
clinical uses of both drugs are limited. Second, the demographics
of HGH and steroid abusers are equivalent. Third, the side ef-
fects associated with the two substances are analogous. Finally,
the addiction potentials of the two drugs are comparable. Yet the
current statutory system treats these two drugs very differently.
This differential treatment is unjustified.
Under the CSA, one of the criteria used to determine the
scheduling of a drug is the number of accepted medical uses.169
Both HGH and steroids have very limited clinical uses. HGH has
only been accepted as a method of treatment for one disease, 7 '
while the FDA recommends steroid treatment for five different
conditions. 7' This difference suggests that the criminal sanc-
tions associated with HGH should be at least as great as, and
certainly not less than, those associated with steroids.'72
,69 21 USC § 812 (1994). Criminal sanctions for violations of the Controlled Substanc-
es Act are most stringent for violations related to drugs or substances under Schedule I
and are least stringent for violations related to drugs or substances under Schedule V.
See 21 USC § 841.
One of the criteria used to determine the Schedule in which a drug or substance
should be placed is whether the drug has any accepted medical uses. In order to be placed
in Schedule I, the drug must have no currently accepted medical use in the United States.
Schedule II drugs may have a currently accepted medical use in the United States or a
currently accepted medical use with severe restrictions. Schedule III, IV, and V drugs all
have currently accepted medical uses in the United States.
, See notes 25-29 and accompanying text.
17 See notes 105-06 and accompanying text.
..2 This type of reasoning, however, is not adopted by the CSA. Under the CSA, the
important factor is whether a drug has any medical use. No distinction exists between a
drug with one medical use and a drug with few or even many medical uses. Hearings on
HR 4658 at 19 (cited in note 159).
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In addition, the demographics of HGH and steroid users do
not support unequal sanctions. Senator Biden stressed that the
chief purpose of the Act was to eliminate steroid abuse among
adolescents. Vaughn Rickert, in a study on the prevalence of
HGH abuse in tenth-grade males, found that 5 percent of his
survey population abused HGH.'73 The survey also found that 5
percent of all tenth graders admitted some steroid abuse.
17 4
This comparable number of adolescent HGH and steroid abusers
suggests that no sound reason exists to provide different penal-
ties for HGH and steroids.'75
Furthermore, although no studies have quantitatively ana-
lyzed the side effects of HGH, qualitative studies on the side
effects associated with HGH and steroids, as well as case studies
examining the side effects of these two substances, suggest that
the two drugs have similar side effects.
For example:
(1) Steroid use leads to liver, cardiovascular, and con-
nective tissue disorders. Similarly, two diseases associ-
ated with HGH-induced acromegaly-cardiomyopathy
and organomegaly-cause disfunction in the heart, the
liver, connective tissue, and other organs.
(2) Continued steroid use can cause infertility in men
and menstrual irregularity and cessation in women.
Similar effects accompany HGH abuse.
(3) Steroid use can cause irreversible abnormal growth
in adolescents, specifically premature epiphyseal clo-
sure. HGH use can cause irreversible abnormal growth
in adolescents, specifically gigantism.
(4) Steroid use increases the risk for cardiovascular
disease by decreasing the HDIJLDL ratio. HGH use
promotes cardiac failure.
' Rickert, 31 Clinical Pediatrics at 725 (cited in note 10).
'7, Id. This study is corroborated by a study by W. F. Buckley finding that 6.6 percent
of high school male seniors had used or were currently using steroids.
"' The Dezelsky study found that as many as 20 percent of males surveyed abused
steroids. See Hainline and Wadler, Contemporary Exercise and Sports Medicine Series at
56 (cited in note 11), citing Dezelsky, Toohey, and Shaw, 37 Bull Narc 49 (cited in note
55). A similar study by Pope and Katz found comparable numbers. See Hainline and
Wadler, Contemporary Exercise and Sports Medicine Series at 73 (cited in note 11), citing
Pope, Katz, and Champoux, 16 Phys Sportsmed 75 (cited in note 55). A comparison of
these studies to the Rickert study is not dispositive because the studies surveyed different
populations. Rickert's survey population was tenth-grade males, while Dezelsky's survey
population was college athletes. This difference in subject group makes the studies non-
comparable.
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(5) Steroid use can alter the user's appearance, includ-
ing altered breast size, increased facial hair, increased
clitoris size, and male pattern baldness. HGH, by caus-
ing diseases such as acromegaly, similarly alters the ap-
pearance of users.
(6) Intravenous use of either steroids or HGH increases
the risk of AIDS and Hepatitis B.
While less is known about the side effects of HGH use than
is known about the side effects of steroid use, some users have
taken this lack of knowledge as a signal that HGH does not have
harmful side effects; therefore, many users have discontinued
steroid use in favor of HGH.'76 Preliminary evidence, however,
suggests that HGH poses dangers equivalent to steroids;77
therefore, any disparity in criminal sanctions based upon per-
ceived differences in the number or scope of side effects is unjus-
tifiable.
Finally, HGH may be as addictive as steroids. 78 Kenneth
Kashkin and Herbert Kleber found that, in the case of steroids,
the need for peer approval and acceptance could contribute to
abuse. 79 HGH users face similar social pressures; therefore, the
desire for peer approval could also lead to HGH abuse. Further-
more, the higher cost of HGH increases the possibility that users
might deal street drugs or commit secondary crimes to support
their habits.
B. HGH Should Be Classified as a Schedule III Drug
HGH closely fits the criteria that define a Schedule III drug.
Under Title 21, Section 812 of the United States Code,"8 ° Sched-
ule III drugs must have potential for abuse, some currently ac-
cepted medical use, and a tendency for moderate or low physical
dependence or high psychological dependence."'
Congress reclassified steroids as a Schedule III drug because
it did not believe that steroids were comparable to Schedule II
" Hainline and Wadler, Contemporary Exercise -and Sports Medicine Series at 72
(cited in note 11).
17 See notes 61-101 and accompanying text. Compare notes 131-150 and accompany-
ing text.
... Kashkin and Kleber, 262 J of the Am Medical Assn at 3167 (cited in note 98).
... See note 101 and accompanying text.
" See 21 USC § 812.
181 Id.
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drugs.182 This reclassification evidenced a desire that drugs
within the same Schedule should be comparable. Therefore, be-
cause the prevalence, the limited medical uses, the possible ad-
dictive nature, and the side effects of HGH are comparable to
those of steroids and other Schedule III drugs such as amphet-
amines, barbiturates, codeine, and morphine,'83 HGH should be
reclassified as a Schedule III drug.
The rates of HGH abuse are similar enough to other Sched-
ule III drugs that HGH should be placed on Schedule III. As
noted above, current studies show that approximately 5 percent
of all high school students abuse HGH,5 4 a figure comparable
to the prevalence of abuse of other Schedule III drugs.'85
Furthermore, HGH has fewer clinical uses than other Sched-
ule III drugs. The only current clinical use of HGH is in the
treatment of growth hormone deficiency in children, whereas
some drugs in Schedule III are used to treat several diseases.88
Although the CSA does not distinguish between drugs with only
one medical use and those with several medical uses,'87 HGH's
sole medical use indicates that it should be treated at least as
stringently as other Schedule III drugs.
All Schedule III drugs have addictive properties. Amphet-
amines, barbiturates, codeine, and steroids all create some psy-
chic dependence. 8 Given that HGH users face the same set of
..2 Hearings on HR 4658 at 14 (cited in note 159).
183 See 21 USC § 812.
' See note 123 and accompanying text.
1 In 1992, 7.1 percent of high school seniors stated that they had used amphet-
amines or stimulants within the past twelve months. Sourcebook of Criminal Justice Sta-
tistics, Table 3.85 at 328 (1992). Among the same group, 2.8 percent of students reported
barbiturate or depressant use. Id. Moreover, 3.3 percent reported use of codeine or mor-
phine. Id. Finally, as discussed above, 6.6 percent of high school seniors abused steroids,
the Schedule III drug most similar to HGH. See notes 174-175 and accompanying text.
" Amphetamines are used to treat manic-depressive or schizoid psychoses and to aid
in dieting by suppressing appetite. Less common uses include relieving mild, temporary
states of depression, and breaking an alcoholic's "vicious circle," in which the alcoholic
drinks to relieve the depression caused by his previous hangover. Richard R. Lingeman,
Drugs From A to Z: A Dictionary 5-6 (McGraw Hill Book Company, 2d ed 1974).
In small doses, barbiturates relieve tension and anxiety. Furthermore, they can be
used as an anticonvulsant in epilepsy, as an analgesic, and as an anesthetic. Id at 15.
Codeine is used as an analgesic for minor pain and is a common ingredient in cough medi-
cine. Id at 46. Morphine is used as a general pain killer. Id at 174.
187 Hearings on HR 4658 at 19 (cited in note 159).
18 Use of amphetamines does not cause physical dependence, but it can cause psychic
dependence. Upon withdrawal, the user may experience fatigue, depression, weakness,
tremors, gastrointestinal disturbances, and a long exhausted sleep, sometimes lasting for
days. Lingeman, Drugs from A to Z at 6 (cited in note 186).
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social motivations as steroid users, a high probability exists that
HGH is addictive. Because Congress was willing to base its deci-
sion to place steroids on Schedule III on Kashkin and Kleber's
social-factor addiction hypothesis for steroids, Congress should
similarly place HGH on Schedule III.189
The side effects associated with. HGH use are similar to
those associated with steroid use. s° On that basis alone, HGH
should properly be classified as a Schedule III drug. The side
effects associated with HGH abuse, however, are more severe
than those associated with other Schedule III drugs, further sup-
porting a Schedule III designation.' s'
Finally, although some of the side effects associated with
other Schedule III drugs are psychological-an area that has not
yet been explored with HGH abuse-most of the physical side
Some evidence indicates that excessive doses of barbiturates can cause psychic de-
pendence if taken for a prolonged period. Withdrawal may cause weakness, violent trem-
ors, anxiety, a rise in temperature, rapid pulse, and violent epileptic seizures which can
be fatal. By the third day, psychoses resembling schizophrenia with paranoid delusions
and vivid hallucinations may occur. These symptoms may last up to two weeks, and some
patients have died of exhaustion during this period. Id at 17, 18.
While addiction to codeine is rare, cases of codeine addition have been documented.
The physical symptoms upon cessation of codeine abuse are minimal. Users may, howev-
er, develop a psychic dependence to codeine. Id at 46.
Morphine is extremely physically and psychically addictive. Withdrawal symptoms
may occur after only three or four days of use. Id at 178.
" The AMA testified before the Senate that "anabolic steroids should not be sched-
uled under ... the CSA since abuse of the drugs does not lead to physical or psychological
dependence as is required for scheduling under the act." Steroids in Amateur and Profes-
sional Sports-The Medical and Social Costs of Steroid Abuse: Hearings Before the Com-
mittee on the Judiciary at 79 (cited in note 155). Despite this testimony, Congress placed
steroids on Schedule III, demonstrating acceptance of Kashkin and Kleber's theory.
" See notes 61-101 and accompanying text. Compare notes 131-150 and accompany-
ing text.
19' Abuse of amphetamines can cause a decrease in saliva, an alteration in blood pres-
sure, tremors, and a faster heartbeat. In extreme doses, amphetamines can cause loss of
appetite, chronic insomnia, restlessness, acute paranoia, delusions, irritability, and com-
bativeness. A severe overdose of amphetamines could also cause death. Lingeman, Drugs
from A to Z at 8-9 (cited in note 186).
Barbiturate use in clinical doses may produce delirium, rashes, nausea, diarrhea,
anxiety, and nervousness. A severe overdose of barbiturates can cause a deep coma, respi-
ratory and kidney failure, and death. Furthermore, barbiturates are a leading mode of
suicide in the United States. Id at 19-20.
The side effects of codeine are minimal. They include constipation and nausea. Id at
48.
The side effects associated with morphine abuse are constipation, nausea, vomiting,
constriction of the pupils, respiratory depression, and a fall in body temperature. Psycho-
logical effects include impairment of mental and physical performance, reduced sex, hun-
ger drives, and changes in mood. A severe overdose of morphine can cause a coma, respi-
ratory failure, shock, and death. Id at 180.
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effects associated with these drugs are neither life-threatening
nor permanent unless massive doses are taken. By contrast, the
side effects of HGH abuse, which may include permanent disfig-
urement and disruption, of internal organs,"92 are clearly more
extreme than the side effects of other Schedule III drugs. This
factor leads to the conclusion that HGH should be treated at
least as stringently as, if not more stringently than, other Sched-
ule III drugs.
C. A Viable Deterrence Strategy Must Include Education and
Social Sanctions
Although equally stringent criminal sanctions should apply
to both steroid and HGH abuse, these sanctions alone would not
fully deter ergogenic drug use. The testimony of Richard Sandlin,
a former steroid abuser, supports this conclusion:
Athletes today are not concerned about [the possibility
for internal damages], they see the immediate results of
anabolic steroids and keep on taking the drugs. Their
only concern is winning at any cost, trading a moment's
worth of fame and fortune for possibly a lifetime of
sickness and disease. I know because during my first
hospitalization in 1983, my doctor stated "if you don't
stop using steroids, they are going to kill you" and my
comment was "at least, I'll die happy" . . . . During [the
time that I took steroids] I believed I was invincible and
nothing which made me so strong could ever be bad for
me. 1
93
Criminal sanctions likely would not deter those, like Sandlin,
who are willing to "win at any cost."
Two reasons explain why criminal sanctions would be inef-
fective with adolescents. First, Richard Sandlin's testimony dem-
onstrates that adolescents often believe they are invulnerable
and immortal. This belief reduces their ability to assess the prob-
ability of being caught, prosecuted, and sentenced for ergogenic
drug use. Furthermore, because adolescents are more likely to
believe that they cannot be harmed by ergogenic drugs, they
"2 See notes 131-150 and accompanying text.
" Abuse of Steroids in Amateur and Professional Sports: Hearings Before the Sub-
committee on Crime, Committee on the Judiciary, House of Representatives, 101st Cong,
2d Sess 50, 51 (1990).
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would not believe that the statute is "right," leading them to ig-
nore the statute.
Second, many adolescents use ergogenic drugs because of, or
at least in conjunction with, peer pressure. Criminal sanctions
most likely would not counter the strong effects of peer pressure.
These two concerns require any viable drug policy that aims
to deter adolescent abuse to include: (1) education programs
focused directly on decreasing peer pressure to take ergogenic
drugs and convincing adolescents both that ergogenic drugs will
harm their bodies and that their drug use will be detected and
punished; and (2) stricter sanctions against the use of ergogenic
drugs by independent sports authorities such as the NCAA, the
10C, and the NFL that would remove one incentive for ergogenic
drug use as well as decrease the number of ergogenic drug users
as adolescent role models.
1. Education.
The first supplement to criminal sanctions is education.
Robert E. Larsen, team physician for the University of Minnesota
football team, testified that education was the "best tool" for
fighting steroid abuse.194 In fact, the American Medical Associa-
tion believes that education will be more of a deterrent to future
ergogenic drug abuse than criminal sanctions.' To succeed,
however, an education program must attack the underlying prob-
lem: the social and peer pressures on the athlete to excel at any
cost and on the cosmetic user to look better at any cost. 196 A \
" Id at 65, 78.
"g The AMA did not support the scheduling of steroids on the CSA. It stated that a
more effective approach to curb steroid abuse was to educate athletes, coaches, and train-
ers about steroid abuse. Steroids in Amateur and Professional Sports-The Medical and
Social Costs of Steroid Abuse: Hearings Before the Committee on the Judiciary at 77, 80
(cited in note 155).
While other organizations do not adopt such a radical stance, most groups recognize
prevention through education as a sound alternative. Ergogenic drugs are a good prospect
for education because the user must initially make a rational decision to use the drugs.
Leslie Southwick, Deputy Assistant Attorney General, stated in testimony before the
Subcommittee on Ci-ime of the House of Representatives: "Anabolic steroids are not like
many drugs of abuse which, over the last twenty years, have been regulated and con-
trolled under the Controlled Substances Act (CSA). Anabolic steroids are not taken to get
'high' or to 'escape from reality,' but to enhance physical performance and to improve
physical appearance". Because the goal of abusing these substances is not the immediate
gratification associated with other drugs, education stands a better chance of deterring
abusers. Hearings on HR 4658 at 14 (cited in note 159).
" Education that consists simply of the dissemination of factual material, however,
will not likely be effective, given the general distrust of the medical community's views on
ergogenic drugs. For instance, Larsen cites an information-based steroid education pro-
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campaign conveying the message that ergogenic drug use is
"cheating" and/or "unfair" might succeed in transforming peer
pressure from a force encouraging ergogenic drug abuse into a
positive influence deterring abuse.
An education plan must also counteract the adolescent's
natural belief that he or she is invincible and immortal. To
achieve this goal, the plan might model itself after the educa-
tional program currently utilized in the war against cigarette
smoking. Media bombardment has successfully transformed
smoking from a socially acceptable habit to a socially unaccept-
able habit,197 and the population of smokers has declined radi-
cally.19s More importantly, adolescents now believe that ciga-
rette smoking can kill. A similar campaign against ergogenic
drugs might be just as successful.
2. Stricter social sanctions against ergogenic drug abuse.
Most people agree that steroids should not be used to boost
performance in athletic competitions. The American College of
Sports Medicine, in a 1987 position statement, denounced steroid
use by athletes as contrary to the ethical principles of athletic
competition.'99 It stated that the eradication of steroid use is in
the best interest of all sports and, as a means to this end, en-
dorsed the development of procedures for drug detection and
policies that exclude from competition those athletes who "refuse
to abide by the rules."2 °0
Removing ergogenic drug abuse and abusers from athletic
competition would deter adolescent abuse of these substances.
First, it would remove ergogenic drug abusers as adolescent role
gram for high school athletes in Oregon that increased the incidence of abuse. Abuse of
Steroids in Amateur and Professional Sports: Hearings Before the Subcommittee on
Crime at 78 (cited in note 193).
1 Id at 76.
198 The percentage of adults who smoke a half pack or more a day has decreased from
20.2 percent in 1986 to 15.7 percent in 1992. Sourcebook of Criminal Justice Statistics,
Table 3.90 at 333 (cited in note 185).
'" American College of Sports Medicine, 19 Medicine and Science in Sports and Exer-
cise 534 (cited in note 34).
200 Id at 537. Three years later, the need for private enforcement of a steroid ban was
echoed by Dr. Jay Cox, former president of the American Orthopaedic Society for Sports
Medicine. In a 1990 address, he stated that "major results [in the war against steroid
abuse] will be achieved only after athletes, teams, schools and federations are willing to
renew a commitment to fair play, deemphasize winning, and no longer tolerate, either
actively or passively, the abuse of drugs in sports." See Cox, 18 Am J of Sports Medicine
at 572 (cited in note 74).
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models. Second, it would remove a key goal of ergogenic drug
use: abusers would be completely banned from competition.
One possible means of achieving this goal is for athletic asso-
ciations to follow the advice of the American College of Sports
Medicine by first threatening and then permanently expelling
any athlete who tests positive for steroid use. If these threats
were credible, many athletes would think twice before using ste-
roids.20' Unfortunately, while many leagues today impose test-
ing and penalty schemes for steroid abuse, permanent expulsion
is not a credible threat."2
No quick solution exists to this problem. Before any system
of self-enforcement can be effective, the leagues and players must
realize that the phrase "winning at any cost" does not include
steroid abuse. Leagues must be willing to sacrifice the short-term
gains of fielding ergogenic drug-enhanced athletes if they desire
steroid-free competition to return.
Unfortunately, the lack of an effective test to detect HGH
use complicates imposing a ban. In fact, without a viable means
to detect HGH use, imposing strict penalties on athletes who test
positive for steroids will only result in users switching to HGH.
In other words, because HGH tests are not effective, the sanc-
tions based upon these tests cannot be effective. Therefore, in
order to provide additional deterrence, leagues may need to im-
pose other penalties to deter HGH use, such as penalizing ath-
"01 The possible efficacy of these athletic sanctions should not be taken lightly. One
study focusing on the apparent lack of improvement of weight lifters at the Junior World
Championships of Weight Lifting from 1981 to 1984 as compared to 1978 and 1981 at-
tributed the lack of improvement to more effective doping control imposed during that
period. K. Virvidakis, G. Sideras, and E. Papadakis, Effect of Doping Control on
Weightlifting Performance, 8 Intl J of Sports Medicine 397 (Dec 1987).
20 For example, Brian Bosworth signed a multiyear football contract after he had
tested positive for steroids. Rick Telander, Mail-order Muscles: How big is the market for
illegal bodybuilding drugs? Sports Illustrated (Nov 22, 1993). This story is only one exam-
ple of the tendency of independent sports agencies to gloss over infractions of their ergo-
genic drug policies. For example, although the NFL has long maintained a policy against
steroid use, it was not until 1987 that it began making a serious effort to enforce that
policy. In 1987, the NFL began testing for steroids in training camp and disciplining those
players who tested positive.
The NCAA drug testing program has similarly floundered. Only since January 1988
have voluntary off-season drug tests been part of the NCAA drug testing program. Under
this program, schools may opt to have a drug testing crew visit the school once each year
to test twenty-four athletes. The school decides who will be tested, when they are tested,
and the penalties for testing positive. LaBree, 31 J of Sports Medicine and Physical Fit-
ness at 618 (cited in note 25); Hearing on Abuse of Steroids (March 22, 1990) at 4; NCAA
does off-season testing for steroids, 16 Physical Sports Medicine 49 (1988).
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letes who are caught with HGH even when use has not been detected.
CONCLUSION
Ergogenic drugs such as steroids and HGH are a widespread
and growing problem among the American population. While the
Anabolic Steroid Control Act of 1990 alleviated some concerns by
placing steroids under the CSA, its failure to impose appropriate
criminal sanctions on HGH use will likely result in future prob-
lems with HGH abuse.
A short-term solution to this problem is to classify HGH,
along with steroids, as a Schedule III drug under the CSA. Any
long-term solution to the underlying problems of ergogenic drugs,
however, must include an education program that convinces
potential abusers that the harms of ergogenic drugs outweigh the
benefits and that it is socially unacceptable to use these drugs.
